First, CREBBP and EP300 are highly enriched at super-enhancers compared to regular enhancers [8] and second, EP300 is recruited by hematopoietic transcription factors to mediate histone acetylation at critical regulatory regions and support BRD4 occupancy in mouse leukemia cells 2 [9]. The gene discussed is EP300; the disease is leukemia.